Recently, NemaMetrix hosted its inaugural ScreenChip workshop in Eugene, OR.  A diverse group of researchers gathered together for a three-day workshop to learn about our technology.  Food, lodging and transportation were provided for our guests as well as lab instruments and reagents.  Additionally, members of the Nemametrix team gave demonstrations and 1-on-1 tutorials on how to use the ScreenChip system.  And as a testament to its ease of use, our customers walked away experts and obtained viable data for their respective research projects.


A collection of C. elegans researchers collaborating during the November 2015 Customer Workshop in Eugene, Oregon.

Needless to say, the workshop was a success!

If you did not make the workshop this time around, there’s no reason to feel left out.  Due to popular demand, a second workshop is in the works for early 2016.  For details and to register, be sure to follow up with via email or phone (details below).

Our Technology, the ScreenChip

The ScreenChip 100 (along with the ScreenChip Dock and supporting components) is our flagship technology.

The NemaMetrix ScreenChip-100 cartridge

ScreenChip-100 | NemaMetrix

Often, the rate-limiting step to furthering research is the challenge of coupling efficiency and simplicity.  The ScreenChip 100 is a compact bench top tool, optimized to run 100 samples before a new chip is needed.  Think of it as a flow-cytometer that uses a whole animal (in this case, microscopic worms).  It shortcuts the experimental process, freeing up more bandwidth to analyze your data, tend to other tasks and develop next steps for publication.

Simply put, the ScreenChip 100 and its supporting components drive results at breakneck speeds.  For more information or to order your own ScreenChip system, visit our online store.

Upcoming: NemaMetrix at the Bi-Annual Anthelmintics Symposium

NemaMetrix will attend the Anthelmintics Bi-Annual Symposium in San Diego, February 9th – 12th, 2016.  Come see our booth and learn about the latest anthelmintic research from our CSO, Janis Weeks whose research is supported by the Bill & Melinda Gates foundation!